Steven M Paul

PubHawk tracks social media discussions for 4 articles by authors named Steven M Paul.

Claim this profile View on PubMed

Mentions

405

Peak: 100 in Oct 2025

across 4 tracked articles

Extended reach

531,327

potential audience

Total likes

3,173

Video views

105,276

Mentions per month

Apr 2020 – Nov 2025

Where it's discussed

Bluesky202 posts
X / Twitter110 posts
News65 articles
Blogs10 articles
YouTube8 videos
Facebook6 posts
Reddit4 posts

Tracked by PubHawk

Most discussed articles

Lancet Jan 2024

Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline-trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial.

Inder Kaul, Sharon Sawchak, Christoph U Correll, et al.

121 mentions

News 54
X 49
Blogs 8
Bluesky 3
+3 more

View analytics →

May 2020

Allopregnanolone: From molecular pathophysiology to therapeutics. A historical perspective.

Steven M Paul, Graziano Pinna, Alessandro Guidotti

106 mentions

Bluesky 100
X 4
YouTube 2

View analytics →

J Pain Symptom Manage Aug 2015

Predictors and Trajectories of Morning Fatigue Are Distinct From Evening Fatigue.

Fay Wright, Gail D'Eramo Melkus, Marilyn Hammer, et al.

103 mentions

Bluesky 99
YouTube 2
News 2

View analytics →

N Engl J Med Feb 2021

Muscarinic Cholinergic Receptor Agonist and Peripheral Antagonist for Schizophrenia.

Stephen K Brannan, Sharon Sawchak, Andrew C Miller, et al.

75 mentions

X 57
News 9
Facebook 4
YouTube 2
+2 more

View analytics →

From PubMed

All publications

Searching PubMed…